26
Apr
The issue of vaccine pricing was discussed at a meeting chaired by Cabinet Secretary Rajiv Gauba. The central government on Monday asked the Serum Institute and Bharat Biotech to lower prices of their COVID-19 vaccines amid criticism from various states who objected to profiteering during such a major crisis. The issue of vaccine pricing was discussed at a meeting chaired by Cabinet Secretary Rajiv Gauba. Now the two companies are expected to come up with revised pricing for their vaccines. The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at…
